NYBC Ventures Investor
New York Blood Center created NYBC Ventures to accelerate innovation in blood-related fields and cellular therapies and technology. The fund was established by New York Blood Center with a $50 million investment and a mission to improve patients' lives by advancing therapeutics, enabling platforms and technologies, and driving collaborations to expand NYBC's impact.
Technology:
Biomarker Discovery & Validation
Industry:
BioPharma AI
Founded Date:
2021-01-01
Investor Type:
Donors
Headquarters:
Boston,Massachusetts,United States,North America
Funding Status:
private
